PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28334607-0 2017 The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration. NAD 65-69 sterile alpha and TIR motif containing 1 Homo sapiens 4-9 28334607-2 2017 SARM1 is the central executioner of the axonal degeneration pathway that culminates in depletion of axonal NAD+, yet the identity of the underlying NAD+-depleting enzyme(s) is unknown. NAD 107-111 sterile alpha and TIR motif containing 1 Homo sapiens 0-5 28334607-2 2017 SARM1 is the central executioner of the axonal degeneration pathway that culminates in depletion of axonal NAD+, yet the identity of the underlying NAD+-depleting enzyme(s) is unknown. NAD 148-152 sterile alpha and TIR motif containing 1 Homo sapiens 0-5 28334607-3 2017 Here, in a series of experiments using purified proteins from mammalian cells, bacteria, and a cell-free protein translation system, we show that the SARM1-TIR domain itself has intrinsic NADase activity-cleaving NAD+ into ADP-ribose (ADPR), cyclic ADPR, and nicotinamide, with nicotinamide serving as a feedback inhibitor of the enzyme. NAD 213-217 sterile alpha and TIR motif containing 1 Homo sapiens 150-155 28334607-3 2017 Here, in a series of experiments using purified proteins from mammalian cells, bacteria, and a cell-free protein translation system, we show that the SARM1-TIR domain itself has intrinsic NADase activity-cleaving NAD+ into ADP-ribose (ADPR), cyclic ADPR, and nicotinamide, with nicotinamide serving as a feedback inhibitor of the enzyme. Adenosine Diphosphate Ribose 223-233 sterile alpha and TIR motif containing 1 Homo sapiens 150-155 28334607-3 2017 Here, in a series of experiments using purified proteins from mammalian cells, bacteria, and a cell-free protein translation system, we show that the SARM1-TIR domain itself has intrinsic NADase activity-cleaving NAD+ into ADP-ribose (ADPR), cyclic ADPR, and nicotinamide, with nicotinamide serving as a feedback inhibitor of the enzyme. Cyclic ADP-Ribose 242-253 sterile alpha and TIR motif containing 1 Homo sapiens 150-155 28334607-3 2017 Here, in a series of experiments using purified proteins from mammalian cells, bacteria, and a cell-free protein translation system, we show that the SARM1-TIR domain itself has intrinsic NADase activity-cleaving NAD+ into ADP-ribose (ADPR), cyclic ADPR, and nicotinamide, with nicotinamide serving as a feedback inhibitor of the enzyme. Niacinamide 259-271 sterile alpha and TIR motif containing 1 Homo sapiens 150-155 28334607-3 2017 Here, in a series of experiments using purified proteins from mammalian cells, bacteria, and a cell-free protein translation system, we show that the SARM1-TIR domain itself has intrinsic NADase activity-cleaving NAD+ into ADP-ribose (ADPR), cyclic ADPR, and nicotinamide, with nicotinamide serving as a feedback inhibitor of the enzyme. Niacinamide 278-290 sterile alpha and TIR motif containing 1 Homo sapiens 150-155 28334607-4 2017 Using traumatic and vincristine-induced injury models in neurons, we demonstrate that the NADase activity of full-length SARM1 is required in axons to promote axonal NAD+ depletion and axonal degeneration after injury. Vincristine 20-31 sterile alpha and TIR motif containing 1 Homo sapiens 121-126 28334607-4 2017 Using traumatic and vincristine-induced injury models in neurons, we demonstrate that the NADase activity of full-length SARM1 is required in axons to promote axonal NAD+ depletion and axonal degeneration after injury. NAD 166-170 sterile alpha and TIR motif containing 1 Homo sapiens 121-126